Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
58
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Downregulation of DcR3 sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis

Chaojie LiangDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Yingchen XuDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Guangming LiDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Tuanjie ZhaoDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Feng XiaDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Guanqun LiDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of China
,
Dongxin ZhangDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of China
&
Jixiang WuDepartment of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 417-428 | Published online: 18 Jan 2017

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hua Ge, Chaojie Liang, Zhixia Li, Dali An, Shulin Ren, Chaosen Yue & Jixiang Wu. (2018) DcR3 induces proliferation, migration, invasion, and EMT in gastric cancer cells via the PI3K/AKT/GSK-3β/β-catenin signaling pathway. OncoTargets and Therapy 11, pages 4177-4187.
Read now

Articles from other publishers (13)

Merve Kulbay, Adeline Paimboeuf, Derman Ozdemir & Jacques Bernier. (2021) Review of cancer cell resistance mechanisms to apoptosis and actual targeted therapies. Journal of Cellular Biochemistry 123:11, pages 1736-1761.
Crossref
Wei-Chin Chang, Yi-Chen Yeh, Hsiang-Ling Ho & Teh-Ying Chou. (2022) Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome. Human Pathology 126, pages 9-18.
Crossref
Farzaneh Karimi & Homa Mollaei. (2021) Potential of miRNAs in cervical cancer chemoresistance. Gene Reports 23, pages 101109.
Crossref
Mahmoud A. Younis, Ikramy A. Khalil & Hideyoshi Harashima. (2020) Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications. Advanced Therapeutics 3:11.
Crossref
Yahui Yang, Yifan Wang, Ligeng Xu & Tianfeng Chen. (2020) Dual-functional Se/Fe complex facilitates TRAIL treatment against resistant tumor cells via modulating cellular endoplasmic reticulum stress. Chinese Chemical Letters 31:7, pages 1801-1806.
Crossref
Cheng‐Yu Yang, Chih‐Kung Lin, Cheng‐Chih Hsieh, Chang‐Huei Tsao, Chun‐Shu Lin, Bo Peng, Yen‐Tzu Chen, Chun‐Chieh Ting, Wei‐Chin Chang, Gu‐Jiun Lin, Huey‐Kang Sytwu & Yuan‐Wu Chen. (2018) Anti‐oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient‐derived tumor xenograft model. Head & Neck 41:5, pages 1260-1269.
Crossref
Guang-Ming Li, Chao-Jie Liang, Dong-Xin Zhang, Li-Jun Zhang, Ji-Xiang Wu & Ying-Chen Xu. (2018) XB130 Knockdown Inhibits the Proliferation, Invasiveness, and Metastasis of Hepatocellular Carcinoma Cells and Sensitizes them to TRAIL-Induced Apoptosis. Chinese Medical Journal 131:19, pages 2320-2331.
Crossref
Hua Ge, Chaojie Liang, Shulin Ren, Chaosen Yue & Jixiang Wu. (2018) Prognostic value of DcR3 in solid tumors: A meta-analysis. Clinica Chimica Acta 481, pages 126-131.
Crossref
Lijuan Xie, Zhuo Chen, Hongyu Liu, Lianyue Guan, Zhanpeng Wang & Wei Li. (2018) Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene. Digestive and Liver Disease 50:3, pages 291-296.
Crossref
Dong-Yu Liang, Wei Huang, Qing Chang & Yan-Qiang Hou. (2018) ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-κB dependent cFLIPL expression. PLOS ONE 13:2, pages e0191545.
Crossref
Junxin Li, Ni Xie, Jianhui Yuan, Lvyan Liu, Qiming Zhou, Xiaohu Ren, Qian Chen, Guizhong Zhang, Qingguo Ruan, Youhai H. Chen & Xiaochun Wan. (2017) DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis. Oncotarget 8:64, pages 107612-107620.
Crossref
Weijiang Zhang, Jianwei Zhou, Xiaoqing Zhu & Huadi Yuan. (2017) MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer. Gene 627, pages 420-427.
Crossref
Rui Zhang, Jian Xu, Jian Zhao & Jinghui Bai. (2017) Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex. Oncotarget 8:28, pages 45213-45223.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.